Fresenius Medical Care (NYSE:FMS) reported quarterly earnings of $0.44 per share which beat the analyst consensus estimate of $0.38 by 15.79 percent. This is a 21.21 percent increase over earnings of $0.36 per share from the same period last year. The company reported quarterly sales of $5.13 billion which beat the analyst consensus estimate of $4.74 billion by 8.29 percent. This is a 0.02 percent increase over sales of $5.13 billion the same period last year.